IDH1 and neoplasm: In multivariate analysis adjusting for IDH1 mutation, age, gender and tumour grade, the combined TP53 mutation showed a trend for improved survival compared to WT, leading us to believe there are specific TP53 mutations accounting for the improved survival in the univariate analysis.